LRRC37B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.460400E-01
Normal-vs-Stage2
1.157410E-01
Normal-vs-Stage3
3.042200E-02
Normal-vs-Stage4
8.905800E-02
Stage1-vs-Stage2
3.403800E-01
Stage1-vs-Stage3
6.781900E-02
Stage1-vs-Stage4
2.953400E-01
Stage2-vs-Stage3
2.349800E-01
Stage2-vs-Stage4
4.322600E-01
Stage3-vs-Stage4
5.262300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.254800E-01
Normal-vs-AfricanAmerican
1.380020E-01
Normal-vs-Asian
5.524000E-01
Caucasian-vs-AfricanAmerican
8.596800E-01
Caucasian-vs-Asian
9.709600E-01
AfricanAmerican-vs-Asian
8.789000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.822560E-01
Normal-vs-Female
3.252600E-01
Male-vs-Female
6.258800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.718600E-01
Normal-vs-Age(41-60Yrs)
3.259400E-01
Normal-vs-Age(61-80Yrs)
2.412400E-01
Normal-vs-Age(81-100Yrs)
8.170200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.619400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.730400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.821600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.502000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.379800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.100800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.644270E-02
Normal-vs-Daily Drinker
1.496960E-01
Normal-vs-Weekly Drinker
3.377500E-02
Normal-vs-Occasional Drinker
4.262200E-01
Normal-vs-Social Drinker
7.030200E-01
Non Drinker-vs-Daily Drinker
2.710800E-01
Non Drinker-vs-Weekly Drinker
5.282000E-01
Non Drinker-vs-Occasional Drinker
1.063780E-01
Non Drinker-vs-Social Drinker
9.078400E-02
Daily Drinker-vs-Weekly Drinker
6.861400E-01
Daily Drinker-vs-Occasional Drinker
4.371000E-01
Daily Drinker-vs-Social Drinker
2.796200E-01
Weekly Drinker-vs-Occasional Drinker
2.539200E-01
Weekly Drinker-vs-Social Drinker
1.735210E-01
Occasional Drinker-vs-Social Drinker
6.337400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.543000E-01
Normal-vs-Grade 2
1.009590E-01
Normal-vs-Grade 3
4.595600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.486990E-01
Grade 1-vs-Grade 3
1.336380E-01
Grade 1-vs-Grade 4
2.543000E-01
Grade 2-vs-Grade 3
8.727800E-01
Grade 2-vs-Grade 4
1.009590E-01
Grade 3-vs-Grade 4
4.595600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.290200E-02
Normal-vs-NonDiabetic
3.373000E-01
Diabetic-vs-NonDiabetic
6.509500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.887500E-02
Normal-vs-NoPancreatitis
2.542600E-01
Pancreatitis-vs-NoPancreatitis
4.728000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.238400E-01
Normal-vs-N1
1.253810E-01
N0-vs-N1
2.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.678000E-01
Normal-vs-TP53-NonMutant
7.771600E-01
TP53-Mutant-vs-TP53-NonMutant
5.016500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
